Macquarie (ASX:MQG) share price struggles amid broker sell rating

This bank share could be expensive…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Macquarie Group Ltd (ASX: MQG) share price is edging lower on Monday afternoon.

At the time of writing, the investment bank's shares are down 0.1% to $174.06.

This compares to a gain of 0.2% by the S&P/ASX 200 Index (ASX: XJO) today.

shadow bear with woman terrified and a falling share price

Image source: Getty Images

Why is the Macquarie share price underperforming?

The weakness in the Macquarie share price on Monday could have been driven partly by a broker note out of Citi last week.

According to the note, in response to its trading update, the broker has retained its sell rating but lifted its price target on the company's shares to $153.00.

Based on the current Macquarie share price, this implies potential downside of 12% over the next 12 months.

What did the broker say?

Citi was pleased with the investment bank's trading update, which revealed that Macquarie expects its first half profit in FY 2022 to be "slightly down" over the second half of FY 2021.

The broker believes this implies a first half net profit in the range of $1.8 billion to $2 billion. This was materially ahead of the consensus estimate of $1.55 billion.

Citi has upgraded its estimates and is now expecting a net profit of $1.9 billion for the half. However, this isn't enough for a more positive rating. This is due to its belief that the Macquarie share price is expensive at the current level.

It commented: "We now forecast $1.9bn for 1H22, with commodities and MacCap gains tracking better than our expectations, despite the negative timing of storage & transport revenue. We see a moderation in earnings in 2H22 as MQG cycles the UK meters gain on sale; and buoyant capital markets activities starts to cycle."

"The stock has reacted positively to the guidance upgrade (+5%), but consensus is largely upgrading on the back of one-time MIC wind-down revenues. At 22x FY23 earnings the stock remains expensive in our view," the broker concluded.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

a couple consider the advice from a man with documents laid out on a table and the man holding a tablet in his hand.
Financial Shares

3 ASX 200 financial shares to sell: experts

ASX 200 financial shares are down 2.5% over six months and up 2.1% in 2026-to-date.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy, hold, sell: NextDC, Hub24, PLS Group shares

The market is pessimistic about the next round of talks between the US and Iran.

Read more »

A team of people giving the thumbs up sign.
Broker Notes

5 ASX 200 shares with renewed buy ratings this week

Brokers have indicated continuing confidence in Cochlear, REA, and several other ASX 200 shares.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Broker reiterates buy ratings on 2 ASX shares

These ASX shares remain worth watching.

Read more »

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

After more than quadrupling investors' money in a year, are PLS shares still a buy?

A leading analyst delivers his outlook for the soaring PLS share price.

Read more »

A young man wearing a bright yellow jumper and glasses purses his lips together and moves them to the side of his face as he wonders about something.
Broker Notes

Buy, hold, or sell? Life360, Iress, Lynas Rare Earths shares

Experts reveal their views.

Read more »

Worried woman calculating domestic bills.
Broker Notes

Why did this broker just lower its outlook on this ASX 200 stock?

Despite a lowered outlook, attractive upside remains.

Read more »